Quinn Opportunity Partners LLC Amgen Inc Transaction History

Quinn Opportunity Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $84,715 - $99,000	-500 Reduced 8.33%	5,500 $938,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $2.28 Million - $2.55 Million	-13,500 Reduced 69.23%	6,000 $1.04 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $3.26 Million - $3.72 Million	19,500	19,500 $3.64 Million

3,084

401M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quinn Opportunity Partners LLC with notifications on news.